← Back to All Filings

Zoetis EVP Acquires $9.4k in Phantom Stock Units (ZTS)

Low SignificanceOctober 14, 2025 at 4:36:31 PM EDT

Zoetis Inc.

$ZTS4CIK: 0001555280

Subscribe to track ZTS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Zoetis EVP Acquires $9.4k in Phantom Stock Units (ZTS)

Company: Zoetis Inc. (ZTS) Form: 4 | Filed: 2025-10-14 Significance: Low

Insider: FULLER JULIE Title: Executive Vice President | Relationship: Officer

Transaction: • Type: Award • Shares: 201.7367 • Price: $46.71 • Value: $9,423.30 • Owned After: 387.6519

Key Insight: This is a routine acquisition of phantom stock units through a company savings plan, not an open-market purchase, indicating low trading significance.

Market Context: The transaction is part of a supplemental savings plan, a common form of executive compensation, and does not necessarily reflect new insider sentiment.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Zoetis Inc. (ZTS)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An Executive Vice President at Zoetis acquired phantom stock units valued at approximately $9,400 as part of a supplemental savings plan. This is a routine, non-discretionary transaction and does not represent a new investment decision by the insider.
  • Market Impact: Neutral. The transaction is too small and its nature (part of a savings plan) is unlikely to influence market perception or stock price.

Company Information

FieldValue
CompanyZoetis Inc.
Ticker SymbolZTS
CIK0001555280
IndustryPHARMACEUTICAL PREPARATIONS [2834]

Insider Information

FieldValue
NameFULLER JULIE
CIK0001839804
Title/PositionExecutive Vice President
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-10
Transaction CodeA (Grant, award, or other acquisition)
Security TypePhantom Stock Unit
Shares Involved201.7367
Price Per Share$46.71
Total Value$9,423.30
Shares Owned After387.6519
Ownership TypeDirect

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is an award of phantom stock units under a savings plan, not an open-market purchase. Such transactions are typically pre-scheduled or automatic and do not signal a change in the insider's outlook on the company. The value is negligible relative to the company's market capitalization.

Volume & Sentiment

  • Expected Volume Impact: None. As this is not an open-market trade, it has no direct impact on trading volume.
  • Sentiment Indicator: Neutral. This type of filing is common and is viewed by the market as part of a standard compensation structure rather than a bullish or bearish signal.

Investment Insights

Positive Market Indicators

  • The acquisition, although routine, incrementally increases the insider's alignment with shareholder interests.

Risk Factors

  • No direct risk factors are indicated by this filing. It is a standard course of business transaction.

Key Takeaways

  1. Routine Compensation: The acquisition is part of the Zoetis Supplemental Savings Plan, as noted in the filing's footnotes.
  2. Not an Open-Market Buy: This is not a discretionary purchase of shares with the insider's own capital, which would have carried more weight.
  3. Low Significance: The small dollar amount and the nature of the transaction render it of low significance for investment analysis.

Contextual Analysis

Timing Significance

  • The timing of the transaction is tied to the mechanics of the savings plan and does not appear to be correlated with any specific market event or inside information.

Transaction Context

  • Footnote 1 clarifies the nature of the transaction: "These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service..." This confirms the transaction is part of a deferred compensation or savings program.
  • Footnote 2 explains that each unit represents a fraction of a phantom share plus cash-equivalents, with its value tied to Zoetis common stock.

Company Context

  • Zoetis is a major player in the animal health industry. This filing represents a minor, operational event within its executive compensation framework and does not provide insight into the company's current performance or strategic direction.

Risk Assessment

Risk Level: Low

Risk Factors

  • This filing does not introduce any new risk factors. The primary risk is misinterpreting this routine award as a bullish insider signal.

Market Considerations

  • Investors should differentiate between discretionary open-market trades and automatic, plan-related acquisitions.
  • This filing is informational and should not be a factor in an investment thesis for ZTS.

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-14 | Data source: SEC EDGAR

Topics:#SECFiling#InsiderTrading#Form4#Zoetis#ZTS#StockMarket#Investing#ExecutiveComp

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.